Parallel Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
PA
LCS
TC
NCM
CF
TCM
NSIM
Parallel Advisors's RNLX Position: Q2 2024 in Review
Parallel Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2024, closing a stake of 60 shares — an estimated $52 sold.
Parallel Advisors first reported a position in RNLX in Q4 2023 and held it in 2 quarters. The position peaked at $52 in Q1 2024. 26 funds tracked by Wall St. Rank hold RNLX as of Q2 2024.
- Parallel Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q2 2024 after selling out during the quarter.
- Parallel Advisors sold 60 Renalytix plc American Depositary Shares shares in Q2 2024, an estimated $52.
- Parallel Advisors first reported a position in Renalytix plc American Depositary Shares in Q4 2023 and held it in 2 quarters.
- Parallel Advisors's Renalytix plc American Depositary Shares position peaked at $52 in Q1 2024.
- 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2024.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.